fda compounding semaglutide warning september 2025 Drug Recalls and Warnings: Recalls for Compounded and Tirzepatide, Wegovy; Facility Letters July 29, 2024: FDA issued

Ozempic is only available as a brand-name drug

Temperature Monitoring and Stability Considerations Temperature excursions represent one of the most common causes of peptide degradation for both lyophilized and reconstituted forms

Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men

On February 8, the drugmaker announced legal action against telehealth company Hims & Hers, asking the court to permanently ban the company from selling unapproved, compounded drugs

There are people who will benefit from greater weight loss, but not everyone needs the most weight loss." Novo Nordisk, the maker of Wegovy and Ozempic, said in a statement Wednesday that it "strongly believes" in semaglutide, the main active ingredient in both its medications